DEDICATE-DZHK6: Randomized, Observer-Blinded, Multi-Center, Event-Driven Trial of TAVI versus SAVR in Patients with Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as assessed by STS-Score
| Institution | Universitätsklinikum Hamburg-Eppendorf (UKE) |
|---|---|
| Project leader | Stefan Blankenberg |
| Site | Hamburg/Kiel/Lübeck |
| Kurzbeschreibung | |
| Project type | Klinische Studie |
| Funding | € 3.732.785,61 |
| Begin | 01.02.2017 |
| End | 31.07.2028 |
| Partnerprojekte |
Förderkennzeichen
81X1710106
Projektnummer
865